

Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB
Oct 27, 2023
Dr. Luciano Costa discusses CAR T therapy in multiple myeloma, including availability improvements, testing in earlier lines of therapy, side effects, new targets, combo CAR Ts, maintenance therapy, open clinical trials, and new CAR T variants. The podcast delves into the significance of CAR-T therapy, advancements in FDA-approved drugs, ongoing clinical trials, maintenance therapy debates, and the importance of early access to CAR-T clinical trials in myeloma treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 4min
Exploring the Role of CAR-T Cell Therapy in Multiple Myeloma Care with a Specialist
03:57 • 1min
Exploring the Use of T Cells and CAR-T Therapy in Cancer Treatment
05:27 • 5min
Advancements in CAR-T Therapy for Multiple Myeloma Patients
10:48 • 22min
Advancements in CAR-T Therapies for Multiple Myeloma
32:37 • 19min
Exploring Maintenance Therapy in CAR-T Cell Treatment
51:13 • 9min
Early Access and Appreciation for CAR-T Clinical Trials in Myeloma Treatment
59:52 • 2min